Evidence map›Paper›PMID 35246226›Full record

ArticleItalian journal of pediatrics2022

A new phenotype of aldolase a deficiency in a 14 year-old boy with epilepsy and rhabdomyolysis - case report.

Lucia Santoro, Dorina Pjetraj, Virtut Velmishi, Carmen Campana, Carlo Catassi, Carlo Dionisi-Vici, Arianna Maiorana

Open access · goldAbstract readCase Reports
In one paragraph

Article in Italian journal of pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Glycogen storage diseases.Nature reviews. Disease primers · 2023
    Review
  5. Glycogen storage diseases: An update.World journal of gastroenterology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Lucia Santoro *Division of Pediatrics, Polytechnic University of Marche, Ospedale Pediatrico "G. Salesi", Ancona, Italy.
Dorina Pjetraj *Division of Pediatrics, Polytechnic University of Marche, Ospedale Pediatrico "G. Salesi", Ancona, Italy. pjetrajdorina@gmail.com.ORCID http://orcid.org/0000-0002-0238-7865
Virtut VelmishiPediatric Service Nr 2 "Mother Teresa" Hospital-Trina, Tirana, Albania.
Carmen CampanaDivision of Metabolism, Department of Pediatric Subspecialties, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
Carlo CatassiDivision of Pediatrics, Polytechnic University of Marche, Ospedale Pediatrico "G. Salesi", Ancona, Italy.
Carlo Dionisi-ViciDivision of Metabolism, Department of Pediatric Subspecialties, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
Arianna MaioranaDivision of Metabolism, Department of Pediatric Subspecialties, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
Bambino Gesù Children's Hospital · ITMarche Polytechnic University · ITMother Teresa Hospital · AL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlycogen storage disease type XII is a rare metabolic disease resulting from Aldolase A deficiency that causes muscle glycogen accumulation, with crisis of rhabdomyolysis and hemolytic anemia. In the very few cases described, rhabdomyolysis crises are caused by fever and/or exercise and can accompany acute hemolytic anemia. Although currently there is no therapy available for this disease, the guidelines for the management of other forms of glycogen storage diseases recommend a nutritional therapy in order to avoid hypoglycemia or prevent exercise-induced rhabdomyolysis. CASE PRESENTATION: In this case report we describe a new phenotype of the disease in a 14-year-old boy, characterized by seizures and rhabdomyolysis. Beside an antiepileptic treatment, we propose a new therapeutic approach based on ketogenic diet in order to supply an energetic substrate for skeletal muscle and neurons.

conclusionsThe anti-epileptic therapy and the dietetic approach were well tolerated by the patient who showed good compliance. This led to a deceleration of the disease with no other acute episodes of seizures and rhabdomyolysis, without any side effects observed.

Indexed as

EpilepsyGlycogen Storage DiseaseRhabdomyolysisAdolescentHumansMalePhenotype24 GSD XIIALDOA DeficiencyAldolase A DeficiencyGlycogen Storage Disease type XIIKetogenic Diet

Identifiers

PMID35246226
PMCPMC8895104
OpenAlexW4214903129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.